Prelude Capital Management’s MEI Pharma MEIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,575
| Closed | -$84K | – | 1748 |
|
|
2021
Q4 | $84K | Hold |
1,575
| – | – | ﹤0.01% | 1375 |
|
|
2021
Q3 | $87K | Buy |
1,575
+425
| +37% | +$23.5K | ﹤0.01% | 1164 |
|
|
2021
Q2 | $66K | Hold |
1,150
| – | – | ﹤0.01% | 1225 |
|
|
2021
Q1 | $79K | Hold |
1,150
| – | – | ﹤0.01% | 1029 |
|
|
2020
Q4 | $61K | Sell |
1,150
-1,448
| -56% | -$76.8K | ﹤0.01% | 727 |
|
|
2020
Q3 | $162K | Buy |
2,598
+1,243
| +92% | +$77.5K | 0.01% | 557 |
|
|
2020
Q2 | $112K | Buy |
+1,355
| New | +$112K | 0.01% | 629 |
|
|
2017
Q4 | – | Sell |
-760
| Closed | -$41K | – | 1436 |
|
|
2017
Q3 | $41K | Sell |
760
-565
| -43% | -$30.5K | ﹤0.01% | 1049 |
|
|
2017
Q2 | $63K | Sell |
1,325
-55
| -4% | -$2.62K | 0.01% | 840 |
|
|
2017
Q1 | $45K | Buy |
+1,380
| New | +$45K | ﹤0.01% | 967 |
|
|
2016
Q4 | – | Sell |
-90
| Closed | -$3K | – | 1631 |
|
|
2016
Q3 | $3K | Buy |
90
+80
| +800% | +$2.67K | ﹤0.01% | 1441 |
|
|
2016
Q2 | $0 | Buy |
+10
| New | – | ﹤0.01% | 1603 |
|